Market Commentary
Market Commentary
Market Commentary: Markets Start the New Year Strong Despite the Chaos in Washington
The vivid pictures and appalling actions in Washington, D.C., Wednesday captured the attention of the globe, but not the interest of markets. The Democratic sweep in the Georgia Senate races didn’t attract a lot of interest from investors either. Neither were markets fazed by the first loss of jobs in a monthly employment report since the recovery began.
Read More
Market Commentary
Market Commentary: S&P 500 Finishes the Year at a Record High, Unemployment Numbers Decrease Slowly
The S&P 500 wrapped up a surprising year with another strong week. The index of large-cap stocks, including dividends, climbed 1.5% and finished 18.4% higher for the year. Figure 1 shows the performance of the S&P 500, ex-dividends, in 2020 and just how far stocks have roared back from their lows.
Read More
Market Commentary
Market Commentary: Trump Signs New Stimulus Package as Vaccine Distribution Continues
The new stimulus package approved by the House and Senate was signed by President Trump Sunday night. The president had proposed upping the aid to individuals to $2,000 after the bipartisan agreement had been reached. Garnering support for that proposal would likely have proven difficult and economic urgency made signing the bill the logical choice. The need for additional support was evidenced by a 1.2% decline in disposable income (Figure 1).
Read More
Market Commentary
Market Commentary: New Support Package to Provide Assistance to Individuals, Businesses and More
The economic slowdown continues. Initial jobless claims climbed 885,000 last week. In the face of additional restrictions and heightened health risks, consumers have scaled back activity. Retail and food service sales dipped 1.1% last month (Figure 1).
Read More
Market Commentary
Market Commentary: First Vaccines Roll Out as Unemployment Claims Remain High
Initial jobless claims reached an 11-week high based on data reported last week. More than 850,000 workers filed initial unemployment claims (Figure 1). While processing delays around the Thanksgiving holiday affected the data, even after adjusting for the break it appears the economic lull continues.
Read More
Market Commentary
Market Commentary: S&P 500 Gains Nearly 11% Last Month After Promising Vaccine News
November turned out to be a month full of news. A surge of COVID-19 cases, the presidential election, vaccine announcements, and slowing economic growth all moved markets. The November employment report provided additional evidence economic growth is decelerating. The economy generated 245,000 new jobs, missing expectations of 463,000 (Figure 1). Unemployment inched lower to 6.7% supported by the slow job growth and more people leaving the labor force.
Read More
Market Commentary
Market Commentary: Dow and S&P Set Records, but Unemployment Still Rising
The economy seems poised to decelerate in coming weeks as data showed slowing economic improvement or outright reversals of the recovery. Income data was mixed. Disposable income fell 0.8% in October as government programs expired. Gains in employment pushed employee compensation up 0.7% as more people returned to work.
Read More
Market Commentary
Market Commentary: Rise in COVID-19 Cases Leads to Market Dip Before Holiday Shopping Season
Retail data were mixed last week. U.S. retail sales rose 0.3% in October and are now 5.7% higher than one year ago. But as Figure 1 shows, the increase was the smallest since the recovery began. Increased coronavirus cases in October likely pressured purchases lower and moved consumers online. Non-store retailers reported a 3.1% increase in sales.
Read More
Market Commentary
Market Commentary: Markets Respond Favorably to News of Second Vaccine’s Positive Results
Special Update A second COVID-19 vaccine announced very positive results in its initial trial. A biotechnology company announced Monday their COVID-19 vaccine was more than 94.5% effective. The study also showed there were few side effects observed in the vaccine trial. The effectiveness is very high and will likely give the world two vaccines to start protecting people in coming months.
Read More
Market Commentary
Market Commentary: COVID-19 Vaccine Shows Positive Results and Market Soars Even After Tight Election
Special Update The first COVID-19 vaccine to announce results reported very positive data early Monday morning. Two notable pharmaceutical and biotech companies announced on Monday their COVID-19 vaccine was more than 90% effective. The study also showed there were no side effects observed in the vaccine trial. The effectiveness is higher than many medical experts expected and represents a major step forward in efforts to contain the virus. News on other vaccine trials is expected in coming weeks and months.
Read More